Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I rather not to find out. Some truths are better not to be disclosed while holding. It could be catastrophic. Better keep it in the low and let ViaDerma spike again at least at 0.03 cents and GTFO
After a month, I received initial, acknowledgement response to my emails to IR (Rich), regarding ongoing discrepancy in licensing revenue reported in financial reports vs announced in official PRs. He stated he has been tied up on another project. I provided requested information. He stated he will find out. I will pass along, if and when, answer is received.
Now I believe you are high. It is alright, can you share your experience at the moment? Are you anxious? Was it crystal or ICE? Are you on acid?
Keep adding everyday , one day it will go 0.0014-18
So, in a nutshell, not sure why posted such if you won’t provide any substancial Intel. Anyways, you claim that we should trust in your word and the insider friend of your friend that is providing you that fictional intel and chill, right?
Darn, you are special.
Chuckles
Please not in green. Unreadable!
Not at all!!! What these big cases have to do with small time punks like us in the OTCM VDRM Dumbest Money’s club ?
Most straightforward examples of the many:
03/02/23 PR - state licensing expands to 11 states ($55K/mo)
- expansion to all 50 in next 12 months
10/24/23 PR - state licensing expanded to 14 states ($70K/mo)
- keep expanding throughout year
Actual licensing revenue recorded in financial reports has been 10 states ($50K/mo) throughout 2023 and 1Q24. IR (Rich) just ignores emails about the discrepancy between official PRs and official financial reports.
Never had a doubt of such, I agree with your thought as well. However, the issue is not the company but the CEO.
The CEO is the biggest concern and could potentially drive the company to the ground
"...& that will happen" Really?? Are you sure about that? What evidence are you relying upon to make that statement? Your gut? Your trick knee? A hunch? If you tell me you are simply trying to keep your chin up and remain position, I understand. But you certainly can't base that conclusion on any record of actual achievements because there are none. Otiko ought to be ashamed, not to mention fired and prosecuted for theft of company cash and for impersonating a CEO.
😂 😂 😂...........now it's about the PPS
Yet.........when that was mentioned several times before MR. SLOPPY said it wasn't. What a 🤡 😂 😢......
Yes but it's all about PPS & that will happen
Assume? What is PR'd and posted on Twitter etc VS what the Financials show should tell you all you need to know 😂 😂
Does anyone else feel like they’ve been misled and lied to?
Referring to a PR as lame....hmmm.... sounds like you may be a non-believer as well?
I feel we will get a P/R no matter how lame
and where are we supposed to go? no buying? no volume?
DB - When a CEO fails to give any PR or update as to why he failed his fiduciary duties in reporting for what he took the $700k loan for and for not incorporating any form of Interest or repayment schedule like with all the VDRM existing loans, than this comes off as very much the same situation as what Madoff did on that bigger level.
And trust me - I have many millions of PURCHASED SHARES AS reasons to be concerned and angry with Otiko!!!
Notice the none believers R all still here LOL
I get how someone who takes about 1hr/11min and magically turns it into TWO HOURS might not get it...
Always interesting and informative speaking to Rich(he's on two stocks I have large positions in), I've done it for about 10 years. My point, which I'm sure flew over many heads is I'm not sharing!
All wagers(any amount) are welcome for ANY challenges to anything I've ever said...the call/my background...? I don't lie/bullshit. Wager amount into escrow account and go from there?
It would seem folks would want info, but these are crazy daz with soy complicating things. Now, run off and have that soi-latte!
Pay no attention to the keyboard behind the curtain. Vitastem works the best especially clear and onward to whatever will utilize his technology. :)
He's 14 and found his Dad's computer again. He's a petulant child who needs a lot of attention. Send him to his room. Ignore him and he'll go away.
1 hr and 59 mins and the end result from that conversation was: VDRM WILL BE FINE? WOW… took 2 hrs to conclude the word, FINE. Must be complicated the situation
1hr 10min 59sec......Sure you did. What could be your motivation to post such nonsense? Are we supposed to be envious or maybe curious of your fictitious chat. "Probably not helpful, or maybe it was." What?
gib·ber·ish
['jib(?)riSH]
noun
unintelligible or meaningless speech or writing; nonsense:
"he talks gibberish"
One post from that guy is annoying lol
I think he has a stuttering post problem the same post two and three times is annoying
Fine? Does he have a bunch more lies to tweet?
Call with Rich Inza today lasted 1hr 10min 59sec...probably not helpful, or maybe it was.
VDRM will be fine!
Ohh definitely and even now we have witness how formidable the doc is to suck blood from his shareholders. I would never underestimate him again, as matter fact, now I will keep my eyes WELL-WIDE-OPEN on any details with him. He is sneaky
By experience it is a waste of time reaching them in person or over the phone. I have seen other dudes doing it in other tickers, AKA: QNTA. The scorpion venom. Agent met the CEO in person and some traveled to DR, they found BS... CEO talked to them sooooo Beautiful and made soooo many promises and told them exactly what they wanted to hear. CEO wont tell you the real deal at all... Do not try to reach him in person, you will waste your money in gas and time
stop double posting !!
What do you want? I am accumulating the stock.
What do you want? I am accumulating the stock.
Sorry typo: Dr Ottiko
Sorry typo: Dr Ottiko
For once can you say something that makes sense?
Never underestimate o tiki
Never underestimate o tiki
Slowly slowly back to 0.0016
Slowly slowly back to 0.0016
Don't think he's based in LA anymore.
Does anyone here live near Los Angeles? Reseda CA?
Stop by and talk to him.
I’m in Texas or else I would
The unfortunate sad reality here is that unless the Doc puts out a fluff piece, we won't see any news because he has nothing to report. Let me repeat that again, he has nothing to report. Let that sink in. Don't you think that if he actually had inked a deal with big pharma or a hospital or an insurance carrier, he would shout that from the rooftops?? Who knows what this guy is doing on a daily basis but he's not working on VDRM. Furthermore he doesn't seem to give a shit either as the price continues to trickle downward.
Laundered… Clean accounting stealing. Chinese style cooking books. This CEO is a piece of work. That 700k, watch, it will be cleaned as well in a year or 2
Great dude diligence here. I had no idea about this previous loan. That is absolutely WILD
No kidding! But DB was a broker and has years and years of experience investing. And I flew the Space Shuttle. What a joke. I spoke with Otiko earlier today, he was watching golf. Wanted me to thank everyone for the new pad he is enjoying. Standby for some earth breaking news on the Nupelo front as it was discovered it has an even better use and is going to turn the market upside-down. I'll be happy to share the news with the board once he gives me the final details. LMFAO
Followers
|
619
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
74600
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |